News

In the third violation subsection, the FDA tells Nephron, “You failed to demonstrate that the method used for sample collection for EM (e.g., use of tubing with a length of about (b)(4) and ...
WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an ...
WIS interviewed current employees, a former employee, Nephron leadership and studied FDA records to breakdown the most recent inspection, the recalls and the company’s prior interactions with ...
Nephron officials did not immediately say if the company had yet responded to the FDA’s warning. Nephron employs 4,000 full- and part-time employees at a 715,000-square-foot campus in an ...
Nephron is currently in a hiring surge, ... She has already ordered the parts to make another one to put into production and hopes to have several of them going at the same time one day.
Company anticipates products to be available in the first quarter of 2023 with initial revenue from this agreement expected in the first half of the year Strengthens the collaboration between ...
VA recalls all Nephron products over contamination concerns All VA facilities were notified of the internal recall on Dec. 6, 2022 and asked to notify affected patients by December 20, 2022.
Check your prescriptions: Fear of contaminated drugs has led the Department of Veterans Affairs to recall all medicines made by Nephron Pharmaceuticals. VA officials told 5 On Your Side they made ...
COLUMBIA — As Nephron Pharmaceuticals Corporation continues its struggle to comply with federal drug regulations, the Lexington County manufacturer has furloughed at least 70 employees without ...
--Nephron Pharmaceuticals Corporation and Sharps Technology, Inc., an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new ...